KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
AcquisitionsAmortization of Deferred ChargesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)DivestmentsFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesSales of Property, Plant and EquipmentShare-based CompensationShares IssuedShort-Term Debt issuances
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Addus HomeCare (ADUS) Asset Writedowns and Impairment (2016 - 2025)

Addus HomeCare (ADUS) has disclosed Asset Writedowns and Impairment for 16 consecutive years, with $515000.0 as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Asset Writedowns and Impairment rose 66.67% year-over-year to $515000.0, compared with a TTM value of $1.6 million through Dec 2025, up 39.43%, and an annual FY2025 reading of $1.6 million, up 39.43% over the prior year.
  • Asset Writedowns and Impairment was $515000.0 for Q4 2025 at Addus HomeCare, up from $367000.0 in the prior quarter.
  • Across five years, Asset Writedowns and Impairment topped out at $1.2 million in Q1 2022 and bottomed at -$856000.0 in Q2 2022.
  • Average Asset Writedowns and Impairment over 5 years is $216850.0, with a median of $257000.0 recorded in 2021.
  • The sharpest move saw Asset Writedowns and Impairment crashed 409.03% in 2022, then skyrocketed 6080.0% in 2024.
  • Year by year, Asset Writedowns and Impairment stood at $218000.0 in 2021, then crashed by 327.52% to -$496000.0 in 2022, then surged by 101.01% to $5000.0 in 2023, then surged by 6080.0% to $309000.0 in 2024, then surged by 66.67% to $515000.0 in 2025.
  • Business Quant data shows Asset Writedowns and Impairment for ADUS at $515000.0 in Q4 2025, $367000.0 in Q3 2025, and $346000.0 in Q2 2025.